Glyxambi (empagliflozin and linagliptin) is used to treat type 2 diabetes Includes glyxambi side effects, interactions and indications. Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes In the united states empagliflozin/linagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus and to The incidence of type 2 diabetes in young people is increasing, but treatments remain limited We aimed to assess the efficacy and safety of an empagliflozin dosing regimen versus placebo and linagliptin versus placebo on glycaemic control in young people with type 2 diabetes.
It is one of several agents of this class now available for treatment of type 2 diabetes This review is based on a pubmed search, clinical trials and personal experience with linagliptin In addition, the us fda approval folder on linagliptin was obtained under the freedom of information act and analyzed What is empagliflozin and linagliptin
WATCH
